#FDA officials agree that comparative #clinicaltrials defeat the purpose of the development program for #biosimilars https://t.co/ZVXepI9Qi8
#FDA officials agree that comparative #clinicaltrials defeat the purpose of the development program for #biosimilars https://t.co/ZVXepI9Qi8